Northwest Biotherapeutics (NWBO) FCF Margin Growth (5y) (2015 - 2026)
Northwest Biotherapeutics (NWBO) FCF Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - |
| 3 | Akari Therapeutics | 1,023.69 Bn | 1,023.69 Bn | - |
| 4 | BeOne Medicines | 468.59 Bn | 463.80 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.01 Bn | 115.76 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.29 Bn | 61.53 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.33 Bn | 63.33 Bn | - |
| 8 | Argenx Se | 55.70 Bn | 50.52 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.79 Bn | 34.78 Bn | 959.66 Mn |
| 10 | Northwest Biotherapeutics | 275.76 Mn | 273.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 309,526.00 |
| Dec 31, 2025 | 30,548.00 |
| Sep 30, 2025 | -229,565.00 |
| Jun 30, 2025 | 37.33 Mn |
| Mar 31, 2025 | -120,276.00 |
| Dec 31, 2024 | -809,098.00 |
| Sep 30, 2024 | -126,389.00 |
| Jun 30, 2024 | -157,356.00 |
| Mar 31, 2024 | -157,606.00 |
| Dec 31, 2023 | -704,840.00 |
| Sep 30, 2023 | -264,126.00 |
| Jun 30, 2023 | -219,208.00 |
| Mar 31, 2023 | 219,788.00 |
| Dec 31, 2022 | 4.44 Mn |
| Sep 30, 2022 | -408,663.00 |
| Jun 30, 2022 | 100,996.00 |
| Mar 31, 2022 | 1.48 Mn |
| Sep 30, 2021 | -864,238.00 |
| Jun 30, 2021 | 808,530.00 |
| Mar 31, 2021 | 293,882.00 |